Ignite Creation Date:
2024-05-06 @ 4:06 AM
Last Modification Date:
2024-10-26 @ 11:44 AM
Study NCT ID:
NCT02456701
Status:
COMPLETED
Last Update Posted:
2017-09-05
First Post:
2015-05-20
Brief Title:
Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379
Sponsor:
Celldex Therapeutics
Organization:
Celldex Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
None
Primary Completion Date:
2016-10-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10-13
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-20
First Submit QC Date:
May 26 2015
Study First Post Date:
2015-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-31
Last Update Post Date:
2017-09-05
Last Update Post Date Type:
ACTUAL